Arkema SA
PAR:AKE
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
70.6
103.05
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Arkema SA
Arkema SA
Total Current Liabilities
Arkema SA
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Arkema SA
PAR:AKE
|
Total Current Liabilities
€2.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
3%
|
CAGR 10-Years
7%
|
|
|
Methanor SCA
PAR:ALMET
|
Total Current Liabilities
€320k
|
CAGR 3-Years
120%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
Arkema SA
Glance View
In the bustling realm of the global chemicals industry, Arkema SA emerges as a pivotal player, engaged in the formulation and crafting of advanced materials and specialty chemicals. Established in 2004, Arkema quickly outgrew its origins as a spin-off from the venerable French oil giant Total S.A., setting in motion its transformation into a nimble and dynamic entity. With a strategic focus on innovation-driven growth, Arkema has carved out a niche in providing sustainable solutions across diverse markets, including construction, transportation, and consumer goods. The company's talent lies in harnessing its three distinct business segments: High Performance Materials, Industrial Specialties, and Coating Solutions. Each segment is tailored to address the unique demands of modern industries, epitomizing Arkema's commitment to enhancing performance while reducing environmental impact. Central to Arkema's financial success is its ability to deliver tailored solutions through its robust portfolio, characterized by innovative polymers, adhesives, and performance additives. By leveraging a vast network of research and development centers, Arkema continues to refine its product offerings, ensuring they meet the evolving needs of its clientele. The company's strategic acquisitions and partnerships further bolster its capabilities, evidencing Arkema's dedication to expanding its technological footprint. Revenue streams flow primarily from its esteemed clientele in North America, Europe, and Asia, as Arkema maintains a global presence bolstered by local expertise. In doing so, Arkema not only sustains its profitability but also fortifies its role as a catalyst for sustainable innovation in the chemical industry.
See Also
What is Arkema SA's Total Current Liabilities?
Total Current Liabilities
2.4B
EUR
Based on the financial report for Sep 30, 2024, Arkema SA's Total Current Liabilities amounts to 2.4B EUR.
What is Arkema SA's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
7%
Over the last year, the Total Current Liabilities growth was 11%. The average annual Total Current Liabilities growth rates for Arkema SA have been 8% over the past three years , 3% over the past five years , and 7% over the past ten years .
You don't have any saved screeners yet